Post Profile






Moving beyond nudges to improve health and health care policies

(Carnegie Mellon University) With countries around the world struggling to deliver quality health care and contain costs, a team of behavioral economists led by Carnegie Mellon University's George Loewenstein believes it's time to apply recent insights on human behavior to inform and reform health policy.
read more

share

Related Posts


Aging power plants provide Trump administration with risks and opportunities

Academics / Sociology : EurekAlert: Social Behavioral

(Carnegie Mellon University) When it comes to the current plans to retire US power plants, Carnegie Mellon University researchers believe we are 'running towards a cliff with no fence.'They found that power plant retirement trends w...

Even with 24/7 access, investors tend to avoid portfolios when expecting bad news

Academics / General Science : Science Codex

Even with 24/7 access to financial data, investors avoid looking at their portfolios when markets are down, according to new research by Carnegie Mellon University economists George Loewenstein and Duane Seppi; Columbia Business Sch...

Carnegie Mellon's George Loewenstein documents the pitfalls of personal loans

Academics / General Science : Science Codex

PITTSBURGH— As an old proverb goes, "before borrowing money from a friend, decide which you need most." New research from Carnegie Mellon University's George Loewenstein and the University of Vienna's Linda Dezsö provides evidence o...

Doctors should be paid by salary, not fee-for-service, argue behavioral economists

Health : EurekAlert: Health

(Carnegie Mellon University) In a Journal of the American Medical Association Viewpoint article, Carnegie Mellon University's George Loewenstein and the University of California, Los Angeles' Ian Larkin outline the problems associat...

Restricting pharmaceutical reps' marketing tactics changes physician prescribing behavior

Academics / Sociology : EurekAlert: Social Behavioral

(Carnegie Mellon University) A team, led by the University of California, Los Angeles' Ian Larkin and Carnegie Mellon University's George Loewenstein, examined restrictions at 19 academic medical centers placed on pharmaceutical rep...

Comments


Copyright © 2016 Regator, LLC